Elevation Evolution – Telegram
Elevation Evolution
175 subscribers
436 photos
30 videos
3 files
196 links
Support Group
Download Telegram
Forwarded from WA Conscious Businesses
ATTENTION - THURSDAY WEEKLY
EMPLOYEE FOCUSED ZOOM SEMINAR
WITH PAUL RICHARDSON

THIS THURSDAY NIGHT - ZOOM PRESENTATION TO EMPLOYEES WITH PAUL RICHARDSON 6PM (WST - Perth)

https://us02web.zoom.us/j/89868968712
Steve Kirsch:

'Pfizer claimed repeatedly in their documents to the FDA that their vaccine would “prevent” COVID-19.

Pfizer knew the injection’s adverse effects would increase with more injections of continuing boosters.

Pfizer knew their injections did not stay at the injection site.

Pfizer knew that the vaccinated group reported far more systemic adverse events than the placebo group.

Pfizer knew that the efficacy of the vaccine waned very quickly over time; by as much as 50% in as little as 1 month after the second dose. How come we weren’t warned about that???

Pfizer defended VAERS (because they didn’t want extra reporting cost burdens).

There are six individuals that signed up for two different clinical trials at two different sites which is really odd.

Pfizer knew vaccinated individuals could still catch COVID-19 and test positive.

There are 1,448 pages comprising 9,704 individual subjects who were excluded from the trials. There isn’t enough detail to know why.

Pfizer paid $2,875,842.00 for their application to the FDA. This is more of a point of information for now.

It is troubling that Pfizer redacts information that is not proprietary that would be very helpful in assessing the data such as the number of doses administered in the ADVERSE EVENTS OF SPECIAL INTEREST” (AESI) document (aka the 5.3.6 document).

Pfizer only tests you for COVID if you have at least one symptom. If the vaccine suppresses symptoms (which it apparently does), then it will falsely appear as if the vaccine reduces the number of COVID cases.

How could anaphylaxis not show up in the Phase 3 trial on any of the 44,000 patients, yet show up as a major safety concern in the post-marketing document?!?'

https://stevekirsch.substack.com/p/10-things-you-should-know-about-the?s=r
Pfizer report from Jan 2021 for the Australian Government shows they had concerns over long-term immunity

"Antibodies and T cells in monkeys declined quickly over 5 weeks after the second dose"

Report: https://www.tga.gov.au/sites/default/files/foi-2389-06.pdf
This is what Stephane Bancel, the founding CEO of Moderna, said about mRNA technology back in 2016.

“Delivery — actually getting RNA into cells — has long bedeviled the whole field. On their own, RNA molecules have a hard time reaching their targets. They work better if they’re wrapped up in a delivery mechanism, such as nanoparticles made of lipids. But those nanoparticles can lead to dangerous side effects, especially if a patient has to take repeated doses over months or years.
Novartis abandoned the related realm of RNA interference over concerns about toxicity, as did Merck and Roche…”

And, from the Vice President of BioNTech.

“I would say that mRNA is better suited for diseases where treatment for short duration is sufficiently curative, so the toxicities caused by delivery materials are less likely to occur,” said Katalin Karikó, a pioneer in the field who serves as a vice president at BioNTech.
Forwarded from Zeee Media 🎙
This is good news, but will anything eventuate from it?

@zeeemedia
👏1